- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02031900
High Resolution Optical Imaging of the Esophagus Using the NvisionVLE™ Imaging System
March 21, 2014 updated by: NinePoint Medical
This is a single center, single arm, open label observational trial of patients undergoing EGD.
The primary objective of this clinical trial is to evaluate the ability of physicians to position the NvisionVLE Optical Probe to acquire an image of an area of the esophagus to identify and discriminate abnormal areas of tissue from normal.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
10
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Males and females >18 years of age undergoing esophagogastroduodenoscopy (EGD).
Description
Inclusion Criteria:
- Males and females over the age of 18 years.
- Patients presenting for an EGD.
- Ability to provide written, informed consent.
- Females who are able to become pregnant, are willing to take a pregnancy test.
Exclusion Criteria:
- Patients on anticoagulation undergoing high risk procedures in accordance to ASGE guideline for the management of antithrombotic agents for endoscopic procedures (2009)*.
- Patients with esophageal varices that preclude biopsies.
- Presence of an esophageal mass that precludes full distention of the balloon from the NvisionVLE catheter.
- Patients with esophageal strictures that would prevent adequate expansion of the balloon from the NvisionVLE catheter.
- Patients with known inflammatory disease, esophageal tears or ulcers, which prohibit full distention of the balloon from the NvisionVLE catheter.
- Patients with known eosinophilic esophagitis.
- Patients that are pregnant.
Patients with a history of hemostasis disorders**.
- Patients on anticoagulation undergoing low risk procedures are not excluded. ** Hemostasis disorders will include, but will not be limited to: patients with hemophilia or other congenitally acquired clotting factor deficiencies, patients with cirrhosis with coagulopathy, patients known to have thrombocytopenia (<100,000 plt/ul) and individuals with von Willibrand's disease or other known platelet malfunction disorders.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Undergoing EGD
|
The NvisionVLE Imaging System is indicated for use as an imaging tool in the evaluation of human tissue microstructure, including esophageal tissue microstructure, by providing two-dimensional, cross-sectional, real-time depth visualization.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The primary endpoint will be the number of patients achieving a VLE (volumetric laser endomicroscopy) image that includes stomach, gastro esophageal junction (GEJ) and esophagus.
Time Frame: 1 day
|
Achieving a VLE image is defined as completing a full 6cm scan.
This will be presented as a percentage of patients.
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The evaluation of procedural workflow and physician interface to the NvisionVLE Imaging Console.
Time Frame: 1 day
|
Procedural workflow and physician interface to the console will be assessed by a questionnaire that will be completed by the investigational staff involved in the procedure.
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Prashanthi Thota, MD, The Cleveland Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2013
Primary Completion (Actual)
January 1, 2014
Study Completion (Actual)
January 1, 2014
Study Registration Dates
First Submitted
January 7, 2014
First Submitted That Met QC Criteria
January 7, 2014
First Posted (Estimate)
January 9, 2014
Study Record Updates
Last Update Posted (Estimate)
March 26, 2014
Last Update Submitted That Met QC Criteria
March 21, 2014
Last Verified
March 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- 13-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Undergoing Esophagogastroduodenoscopy (EGD)
-
NinePoint MedicalCompletedUndergoing Esophagogastroduodenoscopy (EGD)United States
-
Yu-Hsi hsiehUnknownPatients Undergoing Diagnostic EGDTaiwan
-
Dalin Tzu Chi General HospitalCompletedPatients Undergoing Diagnostic EGDTaiwan
-
Saneso Inc.West Virginia UniversityCompleted
-
Dalin Tzu Chi General HospitalCompletedEsophagogastroduodenoscopyTaiwan
-
Yonsei UniversityCompletedEGD ProcedureKorea, Republic of
-
Mineto KamataCompletedEsophagogastroduodensocopy (EGD) ProcedureUnited States
-
Bispebjerg HospitalEnrolling by invitationEsophagogastroduodenoscopy | Anesthetics, LocalDenmark
-
NinePoint MedicalCompleted
-
Affiliated Hospital to Academy of Military Medical...UnknownEsophagogastroduodenoscopyChina
Clinical Trials on NvisionVLE Imaging System: NvisionVLE Imaging Console, NvisionVLE Optical Probe and Inflation Accessory Kit
-
Methodist Health SystemCompletedBile Duct DiseasesUnited States